You can now read 5 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

Red Sox Live

7

7

▲  6th Inning 2 outs

SEC begins inquiry into Aveo

Investigators from the Securities and Exchange Commission have subpoenaed documents from Aveo Pharmaceuticals Inc. relating to an experimental drug for kidney cancer that was rejected by the Food and Drug Administration in June, the Cambridge company said Thursday.

In a regulatory filing, Aveo said it “intends to fully cooperate with the SEC regarding this non-public, fact-finding inquiry.”

Continue reading below

The SEC has informed the company “that this inquiry should not be construed as an indication that any violations of law have occurred or that the SEC has any negative opinion of any person, entity, or security,” according to the filing.

Aveo officials do not intend to comment publicly beyond the filing, a company spokesman said Thursday night.

Robert Weisman can be reached at weisman@globe.com. Follow him on Twitter @GlobeRobW.
Loading comments...
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com
Already a subscriber?
Your city. Your stories. Your Globe.
Yours FREE for two weeks.
Enjoy free unlimited access to Globe.com for the next two weeks.
Limited time only - No credit card required!
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.
Thanks & Welcome to Globe.com
You now have unlimited access for the next two weeks.
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.